Tetrakis(dimethylamido)diboron and tetrahydroxydiboron are herein reported as new catalysts for the synthesis of aryl amides by catalytic condensation of aromatic carboxylic acids with amines. The developed protocol is both simple and highly efficient over a broad range of substrates. This method thus represents an attractive approach for the use of diboron catalysts in the synthesis of amides without having to resort to stoichiometric or additional dehydrating agents.
A metal-free, biomimetic catalytic
protocol for the cyclization
of N-(2-hydroxyethyl)amides to the corresponding
2-oxazolines (4,5-dihydrooxazoles), promoted by the 1,3,5,2,4,6-triazatriphosphorine
(TAP)-derived organocatalyst tris(o-phenylenedioxy)cyclotriphosphazene
(TAP-1) has been developed. This approach requires less
precatalyst compared to the reported relevant systems, with respect
to the phosphorus atom (the maximum turnover number (TON) ∼
30), and exhibits a broader substrate scope and higher functional-group
tolerance, providing the functionalized 2-oxazolines with retention
of the configuration at the C(4) stereogenic center of the 2-oxazolines.
Widely accessible β-amino alcohols can be used in this approach,
and the cyclization of N-(2-hydroxyethyl)amides provides
the desired 2-oxazolines in up to 99% yield. The mechanism of the
reaction was studied by monitoring the reaction using spectral and
analytical methods, whereby an 18
O-labeling
experiment furnished valuable insights. The initial step involves
a stoichiometric reaction between the substrate and TAP-1, which leads to the in situ generation of the catalyst, a catechol
cyclic phosphate, as well as to a pyrocatechol phosphate and two possible
active intermediates. The dehydrative cyclization was also successfully
conducted on the gram scale.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.